{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:12:08Z","timestamp":1782007928082,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijrobp.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T02:28:17Z","timestamp":1644632897000},"page":"592-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial"],"prefix":"10.1016","volume":"115","author":[{"given":"Oscar","family":"Arrieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Hern\u00e1ndez-Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Ramos-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Yamamoto-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"L\u00f3pez-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zyanya Lucia","family":"Zatarain-Barr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G.","family":"Turcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Barrios-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Orozco-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Flores-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cacho-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.02.010_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0002","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fonc.2018.00511","article-title":"Editorial: Central nervous system metastases in lung cancer patients: From prevention to diagnosis and treatment","volume":"8","author":"Hendriks","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0003","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2021.02.044","article-title":"Prophylactic cranial irradiation reduces brain metastases and improves overall survival in high-risk metastatic non-small cell lung cancer patients: A randomized phase 2 study (PRoT-BM trial)","volume":"110","author":"Arrieta","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s12253-019-00598-0","article-title":"A comprehensive meta-analysis of association between EGFR mutation status and brain metastases in NSCLC","volume":"25","author":"Tan","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0006","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fonc.2018.00241","article-title":"The prevention of brain metastases in non-small cell lung cancer by prophylactic cranial irradiation","volume":"8","author":"Witlox","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0007","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.adro.2019.11.002","article-title":"Neurological death is common in patients with EGFR mutant non-small cell lung cancer diagnosed with brain metastases","volume":"5","author":"Ramotar","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijrobp.2021.04.017","article-title":"Prophylactic cranial irradiation in patients with high-risk metastatic non-small cell lung cancer: Quality of life and neurocognitive analysis of a randomized phase II study","volume":"111","author":"Maldonado","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0009","unstructured":"Amsbaugh MJ, Kim CS. Brain metastasis. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470246\/. Accesed on 18th January, 2021."},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0010","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.prro.2011.12.004","article-title":"Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline","volume":"2","author":"Tsao","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-009-0060-9","article-title":"The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline","volume":"96","author":"Gaspar","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0013","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1748-717X-7-181","article-title":"EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases","volume":"7","author":"Lee","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0015","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/1759-7714.13359","article-title":"Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status","volume":"11","author":"Arrieta","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0016","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fphys.2013.00212","article-title":"Ionizing radiation, ion transports, and radioresistance of cancer cells","volume":"4","author":"Huber","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0017","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcell.2019.00004","article-title":"Hypoxia-modified cancer cell metabolism","volume":"7","author":"Al Tameemi","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0019","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.1074\/jbc.273.24.15257","article-title":"Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5\u2032 enhancer","volume":"273","author":"Liu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0020","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1101\/gad.14.16.1983","article-title":"HIF-1 and human disease: One highly involved factor","volume":"14","author":"Semenza","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2005.06.016","article-title":"Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity","volume":"8","author":"Moeller","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0022","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(04)00115-1","article-title":"Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules","volume":"5","author":"Moeller","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0023","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.4161\/cc.3.9.1099","article-title":"Raising the bar: How HIF-1 helps determine tumor radiosensitivity","volume":"3","author":"Moeller","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11596-016-1586-7","article-title":"Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: A systematic review with meta-analysis","volume":"36","author":"Yang","year":"2016","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0025","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1088805","article-title":"Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1alpha","volume":"302","author":"Hagen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0026","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","article-title":"Interfering with tumor hypoxia for radiotherapy optimization","volume":"40","author":"Telarovic","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0027","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1200\/JCO.2005.04.0436","article-title":"Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB\/IV non-small-cell lung cancer","volume":"24","author":"Yasuda","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0028","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2014.01.021","article-title":"Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer","volume":"111","author":"Arrieta","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0029","first-page":"49","article-title":"Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial","volume":"21","author":"Reymen","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.21149\/9916","article-title":"National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages","volume":"61","author":"Barr\u00f3n-Barr\u00f3n","year":"2019","journal-title":"Ext version Salud Publica Mex"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0031","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: An update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0032","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: Summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2022.02.010_bib0033","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57","author":"Horsman","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0034","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/annonc\/mdv370","article-title":"A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)","volume":"26","author":"Dingemans","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0035","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1093\/annonc\/mdv373","article-title":"A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial","volume":"26","author":"Davidson","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0036","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.lungcan.2014.01.001","article-title":"Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB\/IV non-small cell lung cancer (NSCLC)","volume":"83","author":"Reinmuth","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0037","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/0284186X.2017.1386799","article-title":"Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer","volume":"57","author":"Tsakonas","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0038","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2011.12.004","article-title":"Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: A randomised phase II trial","volume":"102","author":"Gamboa-Vignolle","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0039","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21149\/10118","article-title":"Access to lung cancer therapy in the Mexican population: Opportunities for reducing inequity within the health system","volume":"61","author":"Gerson","year":"2019","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0040","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.cllc.2016.05.003","article-title":"Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America","volume":"18","author":"Raez","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0041","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/cam4.673","article-title":"Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: An update meta-analysis","volume":"5","author":"Jiang","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0042","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/cas.13079","article-title":"First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated lung adenocarcinoma","volume":"107","author":"Chen","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0043","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/cancers11081092","article-title":"Combination of whole-brain radiotherapy with epidermal growth factor receptor tyrosine kinase inhibitors improves overall survival in EGFR-mutated non-small cell lung cancer patients with brain metastases","volume":"11","author":"Chen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0044","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2005.07.144","article-title":"Use of magnetic resonance imaging to assess blood-brain\/blood-glioma barrier opening during conformal radiotherapy","volume":"23","author":"Cao","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jtho.2016.06.002","article-title":"Brain metastases from NSCLC: Radiation therapy in the era of targeted therapies","volume":"11","author":"Khalifa","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0046","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLC.2006.n.002","article-title":"Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer","volume":"7","author":"Swinson","year":"2006","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0047","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0048","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-1-60761-869-0_24","article-title":"Regulation of lymphocytes by nitric oxide","volume":"677","author":"Bogdan","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0049","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0161-5890(02)00027-5","article-title":"Nitric oxide as a regulatory and effector molecule in the immune system","volume":"38","author":"Holan","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2051-1426-1-10","article-title":"Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer","volume":"1","author":"Wesolowski","year":"2013","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2022.02.010_bib0051","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.4049\/jimmunol.1103553","article-title":"Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release","volume":"188","author":"Jayaraman","year":"2012","journal-title":"J Immunol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:04:35Z","timestamp":1759745075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0360301622001560"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.02.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}